AnalystsMax MasucciMax Masucci's Stock Forecasts
AnalystsMax Masucci
Analyst Ranking
Bottom 1%
#5481 out of 5510 analysts
Average Return
-27.9%
Win Rate
26%9 out of 35
Risk vs Reward
Poor
Good
Max Masucci's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biolife Solutions IncBLFS | +73.46% | $13.11 | $22.74 | 2023-08-09 - 2024-08-08 | Buy |
Exagen IncXGN | +58.41% | $4.64 | $7.35 | 2026-06-25 - 2026-09-14 | Strong Buy |
Castle Biosciences IncCSTL | +45.96% | $22.91 | $33.44 | 2026-06-25 - 2026-09-14 | Strong Buy |
Biodesix IncBDSX | +36.73% | $20.04 | $27.40 | 2026-06-25 - 2026-09-14 | Strong Buy |
Quanterix CorpQTRX | +30.24% | $36.90 | $48.06 | 2020-10-06 - 2021-10-04 | Strong Buy |
Max Masucci Analyst Color
Get additional color on Max Masucci's coverage of popular stocks
Max Masucci's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
908 Devices IncMASS | 2 | Strong Buy | $13.00 | +33.61% | Maintains | a month ago |
Alpha Teknova IncTKNO | 2 | Strong Buy | $7.00 | +2.64% | Initiates Coverage On | a month ago |
Biodesix IncBDSX | 3 | Strong Buy | $32.00 | +16.79% | Initiates Coverage On | 3 months ago |
Castle Biosciences IncCSTL | 1 | Strong Buy | $40.00 | +19.62% | Initiates Coverage On | 3 months ago |
Exagen IncXGN | 2 | Strong Buy | $8.00 | +8.84% | Initiates Coverage On | 3 months ago |
Bruker CorpBRKR | 1 | Hold | $72.00 | N/A | Maintains | 2 years ago |
Biolife Solutions IncBLFS | 1 | Buy | $25.00 | N/A | Maintains | 3 years ago |
Dermtech IncDMTKQ | 1 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Guardant Health IncGH | 1 | Buy | $53.00 | N/A | Maintains | 4 years ago |
Hologic IncHOLX | 2 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Revvity IncRVTY | 1 | Buy | $164.00 | N/A | Upgrades | 4 years ago |
Genedx Holdings CorpWGS | 3 | Buy | $3.00 | N/A | Maintains | 4 years ago |
Quanterix CorpQTRX | 2 | Hold | $18.00 | N/A | Downgrades | 4 years ago |
Evotec SeEVO | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Nautilus Biotechnology IncNAUT | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Isoplexis CorpISO | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Maxcyte IncMXCT | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Cytek Biosciences IncCTKB | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Rapid Micro Biosystems IncRPID | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Akoya Biosciences IncAKYA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Illumina IncILMN | 3 | Strong Buy | $470.00 | N/A | Maintains | 5 years ago |
Genmark Diagnostics IncGNMK | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
T2 Biosystems IncTTOO | 5 | Strong Buy | $17,500.00 | N/A | Maintains | 6 years ago |
Exact Sciences CorpEXAS | 2 | Strong Buy | $145.00 | N/A | Maintains | 6 years ago |
Chembio Diagnostics IncCEMI | 1 | Hold | $7.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.